| [1] |
Siegel RL, Miller KD, Fuchs HE, et al. Cancer Statistics, 2021[J]. CA Cancer J Clin, 2021，71(1):7-33.
|
| [2] |
Zhang Y, Tian J, Qu C, et al. A look into the link between centrosome amplification and breast cancer[J]. Biomed Pharmacother, 132:110 924.
|
| [3] |
Wu Q, Chen D, Luo Q, et al. Extracellular matrix protein 1 recruits moesin to facilitate invadopodia formation and breast cancer metastasis[J]. Cancer Lett, 2018, 437:44-55.
|
| [4] |
Garrone O, Miraglio E, Vandone AM, et al. Eribulin in advanced breast cancer: safety, efficacy and new perspectives[J]. Future Oncol, 2017, 13(30):2759-2769.
|
| [5] |
McGarry DJ, Armstrong G, Castino G, et al. MICAL1 regulates actin cytoskeleton organization, directional cell migration and the growth of human breast cancer cells as orthotopic xenograft tumours [J]. Cancer Lett，2021，519:226-236.
|
| [6] |
Liu CW, Lin YC, Hung CM，et al. CHM-1, a novel microtubule-destabilizing agent exhibits antitumor activity via inducing the expression of SIRT2 in human breast cancer cells[J]. Chem Biol Interact, 2018，289:98-108.
|
| [7] |
Hohmann T, Dehghani F. The cytoskeleton—A complex interacting meshwork[J]. Cells, 2019, 8(4):362.
|
| [8] |
Linthicum W, Thanh MH, Vitolo MI, et al. Effects of PTEN loss and activated KRAS overexpression on mechanical properties of breast epithelial cells[J]. Int J Mol Sci, 2018, 19(6):1613.
|
| [9] |
Xiang C, Chen J, Fu P. HGF/Met signaling in cancer invasion: the impact on cytoskeleton remodeling[J]. Cancers (Basel), 2017, 9(5):44.
|
| [10] |
Ogden A, Rida PCG, Aneja R. Centrosome amplification: a suspect in breast cancer and racial disparities[J]. Endocr Relat Cancer, 2017，24(9):T47-T64.
|
| [11] |
O’Toole SM, Chapple JP. Primary cilia: a link between hormone signalling and endocrine-related cancers？[J]. Biochem Soc Trans, 2016，44(5):1227-1234.
|
| [12] |
Al Absi A, Wurzer H, Guerin C，et al. Actin cytoskeleton remodeling drives breast cancer cell escape from naturalkiller-mediated cytotoxicity[J]. Cancer Res，2018，78(19):5631-5643.
|
| [13] |
Katschnig AM, Kauer MO, Schwentner R，et al. EWS-FLI1 perturbs MRTFB/YAP-1/TEAD target gene regulation inhibiting cytoskeletal autoregulatory feedback in Ewing sarcoma[J]. Oncogene，2017，36(43):5995-6005.
|
| [14] |
Ebata T, Hirata H, Kawauchi K. Functions of the tumor suppressors p53 and Rb in actin cytoskeleton remodeling[J]. Biomed Res Int, 2016，2016:9 231 057.
|
| [15] |
Yin M, Lu Q, Liu X, et al. Silencing Drp1 inhibits glioma cells proliferation and invasion by RHOA/ ROCK1 pathway[J]. Biochem Biophys Res Commun, 2016, 478(2):663-668.
|
| [16] |
Cascione M, De VM, Toma CC, et al. Morphomechanical and structural changes induced by ROCK inhibitor in breast cancer cells.[J]. Exp Cell Res, 2017，360(2):303-309.
|
| [17] |
Orditura M, Della Corte CM, Diana A, et al. Three dimensional primary cultures for selecting human breast cancers that are sensitive to the anti-tumor activity of ipatasertib or taselisib in combination with anti-microtubule cytotoxic drugs [J]．Breast，2018，41:165-171.
|
| [18] |
Linthicum W, Thanh MH, Vitolo MI, et al. Effects of PTEN loss and activated KRAS overexpression on mechanical properties of breast epithelial cells [J]. Int J Mol Sci，2018, 19(6):1613.
|
| [19] |
Haase G, Gavert N, Brabletz T, et al. The Wnt target gene L1 in colon cancer invasion and metastasis[J]. Cancers (Basel), 2016, 8(5):48.
|
| [20] |
Xiang T, Fan Y, Li C, et al. DACT2 silencing by promoter CpG methylation disrupts its regulation of epithelial-to-mesenchymal transition and cytoskeleton reorganization in breast cancer cells[J]. Oncotarget, 2016, 7(43):70 924-70 935.
|
| [21] |
Meng Z, Moroishi T, Guan KL. Mechanisms of Hippo pathway regulation[J]. Genes Dev, 2016, 30(1):1-17.
|
| [22] |
Chang YC, Wu JW, Wang CW, et al. Hippo signaling-mediated mechanotransduction in cell movement and cancer metastasis[J]. Front Mol Biosci，2020，6:157.
|
| [23] |
Zhang C, Wang F, Gao Z, et al. Regulation of Hippo signaling by mechanical signals and the cytoskeleton[J]. DNA Cell Biol, 2020，39(2):159-166.
|
| [24] |
Osuchowska PN, Wachulak P, Kasprzycka W, et al. Adhesion of triple-negative breast cancer cells under fluorescent and soft X-ray contact microscopy[J]. Int J Mol Sci, 2021，22(14):7279.
|
| [25] |
Wang Y, Xu M, Ke ZJ, et al. Cellular and molecular mechanisms underlying alcohol-induced aggressiveness of breast cancer[J]. Pharmacol Res, 2017, 115:299-308.
|
| [26] |
Mytilinaiou M, Nikitovic D, Berdiaki A，et al.Emerging roles of syndecan 2 in epithelial and mesenchymal cancer progression[J]．IUBMB Life, 2017，69(11):824-833.
|
| [27] |
Povea-Cabello S, Oropesa-ávila M, de la Cruz-Ojeda P, et al. Dynamic reorganization of the cytoskeleton during apoptosis: the two coffins hypothesis[J]. Int J Mol Sci，2017，18(11):2393.
|
| [28] |
Liang Y, Chen H, Ji L, et al. Talin2 regulates breast cancer cell migration and invasion by apoptosis.[J]. Oncol Lett，2018, 16(1):285-293.
|
| [29] |
Chen Z, Yang L, Cui Y, et al. Cytoskeleton-centric protein transportation by exosomes transforms tumor-favorable macrophages[J]. Oncotarget, 2016, 7(41):67 387-67 402.
|
| [30] |
Niu C, Wang X, Zhao M, et al. Macrophage foam cell-derived extracellular vesicles promote vascular smooth muscle cell migration and adhesion[J]. J Am Heart Assoc, 2016, 5(10): e004099.
|
| [31] |
Gabrusiewicz K, Li X, Wei J, et al. Glioblastoma stem cell-derived exosomes induce M2 macrophages and PD-L1 expression on human monocytes[J]. Oncoimmunology, 2018，7(4):e1412909.
|